A new tool to detect kidney disease in chinese type 2 diabetes patients: Comparison of EZSCAN with standard screening methods

Diabetes Technology and Therapeutics

Volumn 13, Issue 9, 2011, Pages 937-943

  Ozaki, Risa ^a   Cheung, Kitty K T ^a   Wu, Enoch ^a   Kong, Alice ^a   Yang, Xilin ^a   Lau, Eric ^a   Brunswick, Philippe ^b   Calvet, Jean Henri ^b   Deslypere, Jean Paul ^b   Chan, Juliana C N ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Impeto Medical   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; IONTOPHORESIS; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE MEASUREMENT; PERIPHERAL VASCULAR DISEASE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SENSORY NEUROPATHY; SMOKING; STROKE; SWEAT GLAND DISEASE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADULT; AGED; ALGORITHMS; CHINA; CREATININE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; IONTOPHORESIS; MALE; MASS SCREENING; MATERIALS TESTING; MIDDLE AGED; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SWEAT GLANDS;

EID: 80052047845     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0023     Document Type: Article

References (29)

1. So WY, Kong AP, Ma RC, Ozaki R, Szeto CC, Chan NN, Ng V, Ho CS, Lam CW, Chow CC, Cockram CS, Chan JC, Tong PC: Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients. Diabetes Care 2006;29:2046-2052. (Pubitemid 44871185)
2. Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421-426. (Pubitemid 32681484)
3. Chan JCN, So WY, Yeung CY, Ko GTC, Lau IT, Tsang MW, Lau KP, Siu SC, Li JKY, Yeung VTF, Leung WYS, Tong PCT: The SURE Study: effects of Structured versus Usual care on Renal Endpoint in type 2 diabetes: a randomized multi-centre translational study Diabetes Care 2009;32:977-982.
4. Tu ST, Chang SJ, Chen JF, Tien KJ, Hsiao JY, Chen HC, Hsieh MC: Prevention of diabetic nephropathy by tight target control in an Asian population with type 2 diabetes mellitus: a 4-year prospective analysis. Arch Intern Med 2010;170:155-161.
5. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, Hu FB: Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009;301:2129-2140.
6. Nelson RG, Tuttle KR: The new KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and CKD. Blood Purif 2007;25:112-114. (Pubitemid 46005761)
7. Chan JC, Gagliardino JJ, Baik SH, Chantelot JM, Ferreira SR, Hancu N, Ilkova H, Ramachandran A, Aschner P: Multi-faceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS). Diabetes Care 2008;32:227-233.
8. Mayaudon H, Miloche PO, Bauduceau B: A new simple method for assessing sudomotor function: relevance in type 2 diabetes. Diabetes Metab 2010;36:450-454.
9. Ramachandran A, Moses A, Shetty S, Thirupurasundari CJ, Seeli AC, Snehalatha C, Singvi S, Deslypere JP: A new non-invasive technology to screen for dysglycaemia including diabetes. Diabetes Res Clin Pract 2010;88:302-306.
10. Stratton IM, Aler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR: Association of glycemia with microvascular and macrovascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-412. (Pubitemid 30609442)
11. Chan JCN, So WY, Ma RCW, Tong PCY, Wong R, Yang X: The complexity of vascular and non-vascular complications of diabetes: the Hong Kong Diabetes Registry. Curr Cardi-ovasc Risk Rep 2011;5:230-239.
12. Ma YC, Zuo L, Chen JH: Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006;17:2937-2944. (Pubitemid 44484685)
13. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
14. Harrell F: Regression Modelling Strategies with applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer-Verlag, 2001.
15. So WY, Yang X, Ma RC, Kong AP, Lam CW, Ho CS, Cockram CS, Ko GT, Chow CC, Wong V, Tong PC, Chan JC: Risk factors in V-shaped risk associations with all-cause mortality in type 2 diabetes-the Hong Kong Diabetes Registry. Diabetes Metab Res Rev 2008;24:238-246. (Pubitemid 351385542)
16. Tong PC, Kong AP, So WY, Ng MH, Yang X, Ng MC, Ma RC, Ho CS, Lam CW, Chow CC, Cockram CS, Chan JC: Hematocrit, independent of chronic kidney disease, predicts adverse cardiovascular outcomes in Chinese patients with type 2 diabetes. Diabetes Care 2006;29:2439-2444. (Pubitemid 44912249)
17. Luk AO, So WY, Ma RC, Kong AP, Ozaki R, Ng VS, Yu LW, Lau WW, Yang X, Chow FC, Chan JC, Tong PC: Metabolic syndrome predicts new onset of chronic kidney disease in 5,829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care 2008;31:2357-2361.
18. Yang XL, So WY, Kong AP, Ho CS, Lam CW, Ng MH, Lyu RR, Yin DD, Chow CC, Cockram CS, Tong PC, Chan JC: Modified end-stage renal disease risk score for Chinese type 2 diabetic patients-the Hong Kong Diabetes Registry. Diabetologia 2007;50:1348-1350. (Pubitemid 46701550)
19. Pop-Busui R, Roberts L, Pennathur S, Kretzler M, Brosius FC, Feldman EL: The management of diabetic neuropathy in CKD. Am J Kidney Dis 2010;55:365-385.
20. Singleton JR, Smith AG: Neuropathy associated with pre-diabetes: what is new in 2007? Curr Diab Rep 2007;7: 420-424. (Pubitemid 350284971)
21. Hsu WC, Yen AM, Liou HH, Wang HC, Chen TH: Prevalence and risk factors of somatic and autonomic neuropathy in prediabetic and diabetic patients. Neuroepidemiology 2009;33: 344-349.
22. Cheshire WP, Freeman R: Disorders of sweating. Semin Neurol 2003;23:399-406. (Pubitemid 38437511)
23. Lauria G, Lombardi R: Skin biopsy: a new tool for diagnosing peripheral neuropathy. BMJ 2007;334:1159-1162. (Pubitemid 46910023)
24. IDF Clinical Guidelines Task Force: Global guideline for type 2 diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med 2006;23:579-593.
25. Chantrel F, Enache I, Bouiller M, Kolb I, Kunz K, Petitjean P, Moulin B, Hannedouche T: Abysmal prognosis of patients with type 2 diabetes entering dialysis. Nephrol Dial Transplant 1999;14:129-136. (Pubitemid 29041882)
26. Williams R, Van Gaal L, Lucioni C; CODE-2 Advisory Board: Assessing the impact of complications on the costs of type II diabetes. Diabetologia 2002;45:S13-S17. (Pubitemid 34762209)
27. The Emerging Risk Factors Collaboration; Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, Holme I, Njolstad I, Fletcher A, Nilsson P, Lewington S, Collins R, Gudnason V, Thompson SG, Sattar N, Selvin E, Hu FB, Danesh J: Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011;364:829-841.
28. Brenner BM, Cooper ME, De Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuizzi G, Snapinin SM, Zhang Z, Shahnifar S; RENAAL Study Investigators: Effects of lo-sartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001; 345:861-869.
29. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Ha-met P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-2572. (Pubitemid 351831357)